AKR1B10 and gastric cancer: In the previous reviews, our researchers found that AKR1B10 is a favorable prognostic indicator in GC and remarkably downregulated in clinical samples.14 Therefore, this study mainly probed the specific relevant molecular mechanism of AKR1B10 in the occurrence and metastasis of GC.